
Keith Mitchell Skubitz MD
Hematologic Oncology
Professor, Lab Medicine & Pathology, University of Minnesota Medical School
Telehealth Available
Request Appointment424 Harvard Street SeMasonic Cancer Center, First Floor, Suite M100Minneapolis, MN 55455
Fax+1 612-626-1441
Overview of Dr. Skubitz
Dr. Keith Skubitz is an oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including M Health Fairview University of Minnesota Medical Center and M Health Fairview Ridges Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 41 years. He is one of 85 doctors at M Health Fairview University of Minnesota Medical Center and one of 25 doctors at M Health Fairview Ridges Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1982 - 1983
- Johns Hopkins University School of MedicineFellowship, Clinical Pharmacology, 1979 - 1981
- University of MinnesotaResidency, Internal Medicine, 1976 - 1979
- Johns Hopkins University School of MedicineClass of 1976
Certifications & Licensure
- MN State Medical License 1978 - 2025
- MD State Medical License 1980 - 1983
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Start of enrollment: 2014 Jun 13
Publications & Presentations
PubMed
- Clinical Benefit of Pegylated Liposomal Doxorubicin and High Prevalence of Pre-Existing Psychiatric Conditions in Patients with Desmoid-Type Fibromatosis.Andrea P Espejo Freire, Keith M Skubitz
Cancers. 2025-01-17 - Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.James M Fleckenstein, Sonia M Najjar, Wolfgang Zimmermann, Christof R Hauck, Quynh Nguyen
European Journal of Clinical Investigation. 2024-12-01 - 1 citationsRAD51C and MYST3 Mutations in a Case of Desmoid-Type Fibromatosis With No Mutation in CTNNB1 or APC.Keith M Skubitz, Paari Murugan
Cureus. 2024-03-01
Grant Support
- IL 2 Liposomes In Lung CancerNational Center For Research Resources1997–2000
- A Pilot Study Of Continuous Infusion Taxol For Refractory MalignanciesNational Center For Research Resources1996–1997
- Granulocyte Membrane Structure And FunctionNational Cancer Institute1985–1989
- Granulocyte Membrane Structure &FunctionNational Cancer Institute1987–1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: